Roche's Tecentriq gets CHMP recommendation as adjuvant treatment for early NSCLC

Retrieved on: 2022-04-25 11:11:02

Tags for this article:

Click the tags to see associated articles and topics

Roche's Tecentriq gets CHMP recommendation as adjuvant treatment for early NSCLC. View article details on hiswai:

Excerpt

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval of Roche's Tecentriq ...

Article found on: www.pharmaceutical-business-review.com